{"entity":{"type":"insider","cik":"0001571862","url":"/insider/0001571862","json_url":"/insider/0001571862.json","name":"Pienta Kenneth","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":7,"first":"2013-11-08","last":"2021-03-17","span_basis":"filed_date"},"name_variants":[{"name":"Pienta Kenneth","source":"filing","n_filings":7,"first_seen":"2013-11-08","last_seen":"2021-03-17"}],"transactions":[{"id":5489847,"accession":"0001209191-21-021293","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-021293","line_url":"/filing/0001209191-21-021293#line-4","is_derivative":false,"issuer_cik":"0001571862","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001571862","owner_cik":"0001571862","owner_name":"Pienta Kenneth","owner_url":"/insider/0001571862","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":439.0,"shares_display":"439","price_per_share":15.0926,"price_display":"15.09","price_state":"stated","total_value":6625.6514,"total_display":"6,625.65","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-16","filed_date":"2021-03-17","scope":"insider"},{"id":5489843,"accession":"0001209191-21-021293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-021293","line_url":"/filing/0001209191-21-021293#line-2","is_derivative":false,"issuer_cik":"0001571862","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001571862","owner_cik":"0001571862","owner_name":"Pienta Kenneth","owner_url":"/insider/0001571862","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":15.0976,"price_display":"15.10","price_state":"stated","total_value":196268.8,"total_display":"196,268.80","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":5518216,"accession":"0000899243-21-007232","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-21-007232","line_url":"/filing/0000899243-21-007232#line-5","is_derivative":false,"issuer_cik":"0001571862","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001571862","owner_cik":"0001571862","owner_name":"Pienta Kenneth","owner_url":"/insider/0001571862","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4274.0,"shares_display":"4,274","price_per_share":15.055,"price_display":"15.06","price_state":"stated","total_value":64345.07,"total_display":"64,345.07","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-18","scope":"insider"},{"id":5518179,"accession":"0000899243-21-007232","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-007232","line_url":"/filing/0000899243-21-007232#line-2","is_derivative":false,"issuer_cik":"0001571862","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001571862","owner_cik":"0001571862","owner_name":"Pienta Kenneth","owner_url":"/insider/0001571862","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":15.1514,"price_display":"15.15","price_state":"stated","total_value":242422.4,"total_display":"242,422.40","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":9204845,"accession":"0000899243-21-007230","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-007230","line_url":"/filing/0000899243-21-007230#line-1","is_derivative":false,"issuer_cik":"0001571862","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001571862","owner_cik":"0001571862","owner_name":"Pienta Kenneth","owner_url":"/insider/0001571862","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2720.0,"shares_display":"2,720","price_per_share":15.066,"price_display":"15.07","price_state":"stated","total_value":40979.52,"total_display":"40,979.52","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-20","filed_date":"2021-02-18","scope":"insider"},{"id":5486942,"accession":"0000899243-21-002947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-002947","line_url":"/filing/0000899243-21-002947#line-1","is_derivative":false,"issuer_cik":"0001571862","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001571862","owner_cik":"0001571862","owner_name":"Pienta Kenneth","owner_url":"/insider/0001571862","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2720.0,"shares_display":"2,720","price_per_share":15.066,"price_display":"15.07","price_state":"stated","total_value":40979.52,"total_display":"40,979.52","shares_owned_after":4720.0,"shares_owned_after_display":"4,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-20","filed_date":"2021-01-22","scope":"insider"},{"id":6075024,"accession":"0001209191-18-004591","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-004591","line_url":"/filing/0001209191-18-004591#line-1","is_derivative":false,"issuer_cik":"0001571862","issuer_name":"Cue Biopharma, Inc.","issuer_ticker":"CUE","issuer_name_source":null,"issuer_url":"/issuer/0001571862","owner_cik":"0001571862","owner_name":"Pienta Kenneth","owner_url":"/insider/0001571862","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-27","filed_date":"2018-01-19","scope":"insider"},{"id":4341144,"accession":"0001181431-13-057810","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-057810","line_url":"/filing/0001181431-13-057810#line-1","is_derivative":false,"issuer_cik":"0001108205","issuer_name":"CURIS INC","issuer_ticker":"CRIS","issuer_name_source":null,"issuer_url":"/issuer/0001108205","owner_cik":"0001571862","owner_name":"Pienta Kenneth","owner_url":"/insider/0001571862","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":2.95,"price_display":"2.95","price_state":"stated","total_value":59000.0,"total_display":"59,000.00","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-08","filed_date":"2013-11-08","scope":"insider"},{"id":5068448,"accession":"0001181431-13-057809","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-057809","line_url":"/filing/0001181431-13-057809#line-1","is_derivative":false,"issuer_cik":"0001108205","issuer_name":"CURIS INC","issuer_ticker":"CRIS","issuer_name_source":null,"issuer_url":"/issuer/0001108205","owner_cik":"0001571862","owner_name":"Pienta Kenneth","owner_url":"/insider/0001571862","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.3691,"price_display":"4.37","price_state":"stated","total_value":43691.0,"total_display":"43,691.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-16","filed_date":"2013-11-08","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001645460","name":"Cue Biopharma, Inc.","url":"/issuer/0001645460","role":"Officer (Chief Medical Officer)","n_filings":5,"first_seen":"2018-01-19","last_seen":"2021-03-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001108205","name":"CURIS INC","url":"/issuer/0001108205","role":"Director","n_filings":2,"first_seen":"2013-11-08","last_seen":"2013-11-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001571862","retrieved_at":"2026-08-21T01:03:17+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}